1. CD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2
   Taoliang Chen et al, 2019, Oncogene CrossRef
2. Recent Advances in Protein Kinase CK2, a Potential Therapeutic Target in Cancer
   V. B. Nipun et al, 2022, Russian Journal of Bioorganic Chemistry CrossRef
3. Biooriented Synthesis of Ibuprofen-Clubbed Novel Bis-Schiff Base Derivatives as Potential Hits for Malignant Glioma: In Vitro Anticancer Activity and In Silico Approach
   Muhammad Ayaz et al, 2023, ACS Omega CrossRef
4. IGF1R and MAPK15 Emerge as Potential Targets of Pentabromobenzylisothioureas in Lung Neuroendocrine Neoplasms
   Ewelina Motylewska et al, 2020, Pharmaceuticals CrossRef
5. Targeting Protein Kinase CK2 Suppresses Prosurvival Signaling Pathways and Growth of Glioblastoma
   Ying Zheng et al, 2013, Clinical Cancer Research CrossRef
6. Deoxynucleosides with benzimidazoles as aglycone moiety are potent anticancer agents
   Mirosława Koronkiewicz et al, 2018, European Journal of Pharmacology CrossRef
7. Synthesis, biological activity and structural study of new benzotriazole-based protein kinase CK2 inhibitors
   R. Swider et al, 2015, RSC Advances CrossRef
8. Proapoptotic effects of novel pentabromobenzylisothioureas in human leukemia cell lines
   Mirosława Koronkiewicz et al, 2012, Medicinal Chemistry Research CrossRef
9. The cytosolic protein kinase CK2 phosphorylates cardiac calsequestrin in intact cells
   Timothy P. McFarland et al, 2011, Molecular and Cellular Biochemistry CrossRef
10. Anticancer Activity of Benzimidazole Derived Isothioureas in Vitro
    M. Koronkiewicz et al, 2013, Annals of Oncology CrossRef
11. Preparation and characterization of CK2 inhibitor-loaded cyclodextrin nanoparticles for drug delivery
    Florent Perret et al, 2013, International Journal of Pharmaceutics CrossRef
12. Benzotriazole: Much More Than Just Synthetic Heterocyclic Chemistry
    Kiran Bajaj et al, 2015, The Chemistry of Benzotriazole Derivatives CrossRef
13. Synthesis of novel polybrominated benzimidazole derivatives—potential CK2 inhibitors with anticancer and proapoptotic activity
    Edyta Łukowska-Chojnacka et al, 2016, Bioorganic & Medicinal Chemistry CrossRef
14. Casein kinases as potential therapeutic targets
    Giorgio Cozza et al, 2016, Expert Opinion on Therapeutic Targets CrossRef
15. The novel benzimidazole derivative, MPTB, induces cell apoptosis in human chondrosarcoma cells
    Te‐Mao Li et al, 2011, Molecular Carcinogenesis CrossRef
16. CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
    Melissa Chua et al, 2017, Pharmaceuticals CrossRef
17. Antitumor activity of the protein kinase inhibitor 1-(β-D-2′-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell lines
    Mirosława Koronkiewicz et al, 2022, BMC Cancer CrossRef
18. Nature of Isomerism of Solid Isothiourea Salts, Inhibitors of Nitric Oxide Synthases, As Studied by 1H–14N Nuclear Quadrupole Double Resonance, X-ray, and Density Functional Theory/Quantum Theory of Atoms in Molecules
    J. N. Latosińska et al, 2012, The Journal of Physical Chemistry A CrossRef
19. Synthesis and antimicrobial and nitric oxide synthase inhibitory activities of novel isothiourea derivatives
    Zygmunt Kazimierczuk et al, 2010, Archives of Pharmacal Research CrossRef
20. Casein kinase 2 inhibition modulates the DNA damage response but fails to radiosensitize malignant glioma cells
    JÉRÔME KROONEN et al, 2012, International Journal of Oncology CrossRef
21. Polymeric nanoparticles for targeted drug delivery system for cancer therapy
    Farha Masood, 2016, Materials Science and Engineering: C CrossRef
22. Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives
    Konrad Chojnacki et al, 2017, Bioorganic Chemistry CrossRef
23. Recent advances in the discovery of small molecules targeting glioblastoma
    Guilherme Felipe dos Santos Fernandes et al, 2019, European Journal of Medicinal Chemistry CrossRef
24. Inhibiting CK2 among Promising Therapeutic Strategies for Gliomas and Several Other Neoplasms
    Emanuela B. Pucko et al, 2022, Pharmaceutics CrossRef